Home | News | UQ vaccine technology ‘promising’ but risks to COVID-19 strategy were too great: study
Associate Professor Keith Chappell. Picture: Liam Kidston

UQ vaccine technology ‘promising’ but risks to COVID-19 strategy were too great: study

Australia’s homegrown COVID-19 vaccine candidate had potential but the false positives on HIV tests were too great a hurdle to move it into further trials, a study published this week has confirmed.

Please login below to view content or register for a 4 week FREE Trial.

Membership Login

Get the news delivered straight to your inbox

Receive the top stories in our weekly newsletter Sign up now

To continue onto Campus Review, please select your institution.